000 01347 a2200361 4500
005 20250516151208.0
264 0 _c20140922
008 201409s 0 0 eng d
022 _a1873-426X
024 7 _a10.1016/j.carres.2013.04.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTóth, Marietta
245 0 0 _aSynthesis of 2-(β-D-glucopyranosylamino)-5-substituted-1,3,4-oxadiazoles for inhibition of glycogen phosphorylase.
_h[electronic resource]
260 _bCarbohydrate research
_cNov 2013
300 _a196-204 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xchemical synthesis
650 0 4 _aGlycogen Phosphorylase, Muscle Form
_xantagonists & inhibitors
650 0 4 _aMolecular Structure
650 0 4 _aMuscle, Skeletal
_xenzymology
650 0 4 _aOxadiazoles
_xchemical synthesis
650 0 4 _aRabbits
650 0 4 _aStructure-Activity Relationship
700 1 _aSzőcs, Béla
700 1 _aKaszás, Tímea
700 1 _aDocsa, Tibor
700 1 _aGergely, Pál
700 1 _aSomsák, László
773 0 _tCarbohydrate research
_gvol. 381
_gp. 196-204
856 4 0 _uhttps://doi.org/10.1016/j.carres.2013.04.025
_zAvailable from publisher's website
999 _c22750492
_d22750492